Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 151–154 of 154 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05810623	Single-Dose Intravesical Chemotherapy After Diagnostic URS(MINERVA)	not yet recruiting	Phase 3	394	David D'AndreaOTHER	1	Apr 12, 2023	clinicaltrials
NCT05241561	Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients(Cabo-POLARIS)	not yet recruiting	Phase 2	24	Centre Hospitalier Universitaire de BesanconOTHER	1	Jun 1, 2022